The impact of home treatment and self-administration of omalizumab on chronic urticaria

BACKGROUND: Patients suffering from Chronic Spontaneous Urticaria (CSU) may be recalcitrant to treatment with high dose second-generation antihistamines. These patients are, according to international guidelines, eligible to treatment with omalizumab. Treatment with omalizumab has proven to be very...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiuff, Anne Christine, Knudsgaard Wiis, Malthe Alexander, Heilskov, Sofine, Frølunde, Anne Sofie, Sørensen, Jennifer Astrup, Deleuran, Mette, Thomsen, Simon Francis, Vestergaard, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731880/
https://www.ncbi.nlm.nih.gov/pubmed/36531648
http://dx.doi.org/10.1016/j.waojou.2022.100725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731880/
https://www.ncbi.nlm.nih.gov/pubmed/36531648
http://dx.doi.org/10.1016/j.waojou.2022.100725

Ejemplares similares